1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Selexipag
Trade Name:
Uptravi
Manufacturer/Distributor:
Actelion Pharmaceuticals Ltd.
Classification:
Prostacyclin receptor antagonist
Vasodilating agent
ATC Class:
B01AC - platelet aggregation inhibitors excluding heparin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2016/01/19
Date Marketed in Canada (yyyy/mm/dd):
2016/04/21
Presentation:
Tablet: 200 mcg. DIN: 02451158
Tablet: 400 mcg. DIN: 02451166
Tablet: 600 mcg. DIN: 02451174
Tablet: 800 mcg. DIN: 02451182
Tablet: 1000 mcg. DIN: 02451190
Tablet: 1200 mcg. DIN: 02451204
Tablet: 1400 mcg. DIN: 02451212
Tablet: 1600 mcg. DIN: 02451220
Comments:
For the long-term treatment of idiopathic pulmonary arterial hypertension, heritable pulmonary arterial hypertension, pulmonary artery hypertension associated with connective tissue disorders and pulmonary artery hypertension associated with congenital heart disease, in adult patients with WHO functional class (FC) II–III to delay disease progression.
Back to:
Drug Product Listings 
